What’s in a name? How changing emphasis can be a game changer
What’s in a name? How changing emphasis can be a game changer
The modern digital lab will truly transform how biopharmaceutical products are created and brought to market
GPs should embrace new technologies to save time and get answers more quickly
Simon Jones, VP Global Products, at PRISYM ID, explains how unique label management software is helping to get products into clinical trials quickly
For pioneers and prospectors the new healthcare landscape offers a wealth of opportunity to engage more effectively with healthcare professionals
Healthcare systems have changed forever as a result of COVID-19. How should pharma respond to the new rules of engagement?
The key to successful collaboration between human specialists and AI is to identify areas in which people excel
Conclusio’s Johnny Skillicorn-Aston and James Roach consider the true meaning of patient-centricity in clinical trials
Blockchain is quickly moving from interesting pilots to clear use cases as a source of trust
The NHS Long Term Plan and what the industry response should be
Simon Grime, of Wilmington Healthcare, explains the principles of exchanging value with customers to gain trust and consent
Tony Cordrey, vice president of European Strategic Operations Accord Healthcare, stresses the importance of ensuring consistency and continuity in medicines supply
Is Europe catching up (or pioneering the way) in digital therapeutics?
Emma Knott, associate director and head of Social Media at Publicis Resolute, says there’s power in pharma’s core narrative
Duncan Arbour, SVP Innovation, Syneos Health Communications Europe, on the need for being faster to what really matters – finding the right protocols for your patients